Evidence map›Paper›PMID 42542239›Full record

ArticleDevelopmental biology2026

Fibulin-1 is required for microvascular integrity in the developing brain and retina.

Xuanyu Chen, Harshit Singhania, Syed Adeel H Zaidi, Ishita Tandon, Roger I Grant, Ruth B Caldwell, Marion A Cooley

Abstract read
In one paragraph

Article in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xuanyu ChenDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA. Electronic address: xuachen@augusta.edu.
Harshit SinghaniaDepartment of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, 30912, USA. Electronic address: hsinghanai@augusta.edu.
Syed Adeel H ZaidiVascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA. Electronic address: syezaidi@augusta.edu.
Ishita TandonImmunology Center of Georgia, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA. Electronic address: itandon@augusta.edu.
Roger I GrantDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. Electronic address: ian.grant@nih.gov.
Ruth B CaldwellVascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA; Culver Vision Discovery Institute, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA. Electronic address: rcaldwel@augusta.edu.
Marion A CooleyDepartment of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, 30912, USA. Electronic address: mcooley@augusta.edu.

Funding

Module 3: Gene Expression/ProteomicsP30EY031631 · NEI · AUGUSTA UNIVERSITY · PI Xingjun Fan · 2020 to 2026
$3.6M
Myeloid glycolysis in pathological ocular angiogenesisR01EY030500 · NEI · AUGUSTA UNIVERSITY · PI CALDWELL, RUTH B, HUO, YUQING · 2019 to 2023
$2.6M
Adenosine receptor 2A in subretinal fibrosisR01EY033737 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Ruth B Caldwell, YUQING HUO · 2022 to 2026
$2.1M
"Myeloid PFKFB3 in subretinal fibrosis"R01EY033369 · NEI · AUGUSTA UNIVERSITY · PI CALDWELL, RUTH B, HUO, YUQING · 2022 to 2025
$1.6M
Myeloid ACAT1 in ischemic retinopathyR01EY035683 · NEI · AUGUSTA UNIVERSITY · PI Ruth B Caldwell, Modesto Antonio Rojas · 2024 to 2026
$1.2M
NEI NIH HHS P30 EY031631NEI NIH HHS R01 EY030500NEI NIH HHS R01 EY033369NEI NIH HHS R01 EY033737NEI NIH HHS R01 EY035683
6 · The paper itself

Abstract

Vascularization of the central nervous system and the postnatal retina proceeds through angiogenic growth that relies in part on the basement membrane (BM) to support endothelial cell-cell interactions and maintain barrier integrity during vessel formation. In addition to the core structural components of the BM, matricellular proteins are present as minor constituents, however, their contributions to endothelial cohesion and barrier stability during angiogenesis remain poorly defined. Here, we identify the matricellular protein Fibulin-1 (Fbln1), a regulator of cell-matrix interactions, as an essential factor during mid-gestation that prevents the formation of dilated, tortuous capillaries that give rise to glomeruloid vascular lesions and intracerebral hemorrhage. Fbln1-deficient brains exhibit vascular malformations characterized by reduced type IV collagen deposition and diminished CD31 localization at endothelial junctions. Although overall pericyte coverage across the vasculature is maintained, the glomeruloid lesions lack pericyte investment. In the developing retina, loss of Fbln1 similarly results in hemorrhage and tortuous capillaries with glomeruloid vascular abnormalities that disrupt the formation of both the superficial and deep vascular plexuses. Together, these findings demonstrate that Fbln1 is a critical determinant of brain and retinal vascular development and is required to preserve endothelial barrier integrity during angiogenesis.

Indexed as

BrainCalcium-Binding ProteinsRetinaRetinal VesselsAngiogenesisAnimalsBasement MembraneCollagen Type IVMiceMice, KnockoutNeovascularization, PhysiologicPericytesCalcium-Binding ProteinsCollagen Type IVfibulinFamilial exudative vitreoretinopathyGlomeruloid vascular abnormalitiesIntracerebral hemorrhageIntraretinal hemorrhageRetinaTortuous capillaries

Identifiers

PMID42542239
PMCPMC13693574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.